Cargando…

Highly potent, fully recombinant RANTES analogues represent promising new candidate microbicides

Detalles Bibliográficos
Autor principal:	Hartley, Oliver
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716963/ http://dx.doi.org/10.1186/1742-4690-3-S1-S52

Ejemplares similares

Live microbial microbicides for HIV
por: Hamer, Dean, et al.
Publicado: (2006)

Development of a live topical microbicide for women
por: Xu, Qiang, et al.
Publicado: (2006)

Microbicide development: multiple targets, multiple mechanisms
por: Shattock, Robin
Publicado: (2006)

Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
por: Moore, John P
Publicado: (2006)

Multiple dosage forms of the NNRTI microbicide dapivirine: product development and evaluation
por: Romano, Joseph
Publicado: (2006)

Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
por: Herold, Betsy C
Publicado: (2006)

ARV formulated microbicides big promise; as world waits vaccine
por: Ondari, Ronald Orutwa, et al.
Publicado: (2009)

Development of a CCR5-tropic HIV-1 fusion inhibition assay amenable to high-throughput screening for topical microbicides
por: Beer, B, et al.
Publicado: (2006)

A recombinant attenuated candidate vaccine that efficiently and persistently protects against bovine leukemia virus in herds
por: Rodríguez, Sabrina M, et al.
Publicado: (2014)

Fully automatic planning of the long-axis views of the heart
por: Hayes, Carmel, et al.
Publicado: (2013)

Entities, relations, events: representing biomolecular semantics
por: Pyysalo, Sampo
Publicado: (2010)

Fully automated segmentation of left atrium and pulmonary veins in late gadolinium enhanced MRI
por: Tao, Qian, et al.
Publicado: (2016)

Recombinant proteins in plants
por: Rech, Elibio, et al.
Publicado: (2014)

Fully automated pixel-wise myocardial blood flow quantification with first-pass perfusion CMR
por: Hsu, Li-Yueh, et al.
Publicado: (2016)

WT1 peptide analogue WT1-126Y enhances leukemia lysis
por: Alqudaihi, Ghofran, et al.
Publicado: (2014)

Algal Lectins as Potential HIV Microbicide Candidates
por: Huskens, Dana, et al.
Publicado: (2012)

Potent suppression of HIV viral replication by a novel inhibitor of Tat
por: Mousseau, Guillaume, et al.
Publicado: (2012)

Achieving the promise of universal coverage – the role for strategic purchasing
por: Hanson, Kara
Publicado: (2014)

New Candidate Biomarkers in the Female Genital Tract to Evaluate Microbicide Toxicity
por: Fields, Scott, et al.
Publicado: (2014)

Fully-automatic, patient-specific 3D aortic arch modeling for patient treatment with aortic arch anomalies
por: Leonardi, Benedetta, et al.
Publicado: (2012)

DNA copy number variations in drug reaction with eosinophilia and systemic symptoms (DRESS) identifying 2 new candidates genes
por: Bursztejn, Anne-Claire, et al.
Publicado: (2014)

Cross-border health care represents a key issue in the field of rare diseases
por: Facchin, Paola
Publicado: (2010)

PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting
por: Myerson, Jacob W, et al.
Publicado: (2012)

DNA vaccines expressing conserved elements provide potent and broad immune responses
por: Pavlakis, GN, et al.
Publicado: (2012)

P100 Potent inhibition of dermatophyte fungi by Australian native jarrah honey
por: Fernandes, Kenya, et al.
Publicado: (2022)

Mandated community treatment: a promising concept for world psychiatry?
por: Monahan, John
Publicado: (2007)

Bacterial anticancer weapons: a promising tool to fight cancer
por: Chakrabarty, Ananda M
Publicado: (2010)

Level of evidence for promising subgroup findings in a negative trial
por: Tanniou, Julien, et al.
Publicado: (2013)

O044 PROMISing questionnaires to measure sleep disturbance and impairment
por: Antonov, A, et al.
Publicado: (2021)

A novel Plasmodium vivax vaccine based on recombinant chimpanzee adenovirus ChAd63 and MVA expressing TRAP
por: Bauza, Karolis, et al.
Publicado: (2012)

48. TOPICAL CAPTOPRIL: A PROMISING THERAPEUTIC AVENUE FOR LYMPHEDEMA TREATMENT
por: Brown, Stav, et al.
Publicado: (2022)

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target
por: Phogat, SK, et al.
Publicado: (2009)

Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides
por: Tintori, Cristina, et al.
Publicado: (2018)

Winnow based identification of potent hERG inhibitors in silico: comparative assessment on different datasets
por: Marchese Robinson, Richard L, et al.
Publicado: (2012)

Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo
por: Corrales, Leticia, et al.
Publicado: (2013)

Text-based similarity searching for hit- and lead-candidate identification
por: Hähnke, Volker
Publicado: (2012)

HSV Neutralization by the Microbicidal Candidate C5A
por: de Witte, Lot, et al.
Publicado: (2011)

Development of Mycobacterium tuberculosis attenuated strains as live vaccine candidates for tuberculosis
por: Villela, Anne, et al.
Publicado: (2014)

454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8
por: Ofek, G, et al.
Publicado: (2012)

Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
por: Utsunomiya, Atae
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_okiqv7fa5n22dcpj2po85tnla1